Serumanti-PLA2R antibody predicted treatment outcome in idiopathic membranous nephropathy
Objective To explore the predictive value of serum phospholipase A2 receptor antibody in determining the efficacy of rituximab in the treatment of idiopathic membranous nephropathy(IMN).Methods From August 1,2017 to May 31,2020,a total of 120 IMN patients received rituximab for the first time or dur...
Saved in:
| Main Authors: | Zhang Xue-qin, Jiang Hong, Yang Shu-fen, Zhao Hong-juan, Lu Chen |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2021-01-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/thesisDetails?columnId=57904269&Fpath=home&index=0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The study of correlation between serum anti-phospholipase A2 receptor antibody and clinicopathology feature and the efficacy in patients with idiopathic membranous nephropathy
by: LI Wen-dong, et al.
Published: (2020-01-01) -
The correlation between anti-phospholipase A2 receptor antibodies and hypercoagulability in patients with idiopathic membranous nephropathy
by: Yunyun Liu, et al.
Published: (2024-12-01) -
Analysis of the correlation between serum anti-PLA2R antibodies and thromboembolic events in patients with idiopathic membranous nephropathy
by: Sun Miao-xin, et al.
Published: (2025-07-01) -
Clinical analysis of low-dos erituximab in the treatment of refractory idiopathic membranous nephropathy
by: Yuan Zhong-fei, et al.
Published: (2021-01-01) -
Study on predictors for treatment efficacy of rituximab in patients with PLA2R-negative primary membranous nephropathy
by: XU Lili, HU Xiaofan, LI Hao, WANG Weiming
Published: (2025-06-01)